- Home
- ARCB vs RXRX Comparison
ARCB vs RXRX Comparison
Compare ARCB & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCB
- RXRX
- Stock Information
- Founded
- ARCB 1923
- RXRX 2013
- Country
- ARCB United States
- RXRX United States
- Employees
- ARCB N/A
- RXRX N/A
- Industry
- ARCB Trucking Freight/Courier Services
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- ARCB Industrials
- RXRX Health Care
- Exchange
- ARCB Nasdaq
- RXRX Nasdaq
- Market Cap
- ARCB 1.6B
- RXRX 1.8B
- IPO Year
- ARCB N/A
- RXRX 2021
- Fundamental
- Price
- ARCB $68.78
- RXRX $5.03
- Analyst Decision
- ARCB Buy
- RXRX Buy
- Analyst Count
- ARCB 13
- RXRX 5
- Target Price
- ARCB $92.92
- RXRX $7.00
- AVG Volume (30 Days)
- ARCB 295.4K
- RXRX 29.8M
- Earning Date
- ARCB 08-01-2025
- RXRX 08-07-2025
- Dividend Yield
- ARCB 0.70%
- RXRX N/A
- EPS Growth
- ARCB 50.16
- RXRX N/A
- EPS
- ARCB 7.55
- RXRX N/A
- Revenue
- ARCB $4,109,676,999.00
- RXRX $59,790,000.00
- Revenue This Year
- ARCB $0.24
- RXRX $23.51
- Revenue Next Year
- ARCB $6.18
- RXRX $53.87
- P/E Ratio
- ARCB $9.05
- RXRX N/A
- Revenue Growth
- ARCB N/A
- RXRX 29.32
- 52 Week Low
- ARCB $55.19
- RXRX $3.79
- 52 Week High
- ARCB $129.83
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- ARCB 56.53
- RXRX 52.35
- Support Level
- ARCB $67.39
- RXRX $4.78
- Resistance Level
- ARCB $69.83
- RXRX $6.07
- Average True Range (ATR)
- ARCB 2.67
- RXRX 0.45
- MACD
- ARCB 0.30
- RXRX 0.04
- Stochastic Oscillator
- ARCB 71.39
- RXRX 44.97
About ARCB ArcBest Corporation
ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.